Innovating in the life sciences and health-care sector? You can’t escape the regulators! Before you make a costly mistake, learn from the experts who have been through the process before.
Whether you’re working on a therapeutic, an in vitro diagnostic or a medical device, come find out how to identify and mitigate challenges along the path to regulatory approval.
Innovating in the life sciences and health-care sector? You can’t escape the regulators! Before you make a costly mistake, learn from the experts who have been through the process before.
Whether you’re working on a therapeutic, an in vitro diagnostic or a medical device, come find out how to identify and mitigate challenges along the path to regulatory approval.
Innovative Drug Pipeline Solutions: Medicinal Chemistry, Process Chemistry, cGMP API Manufacturing. 105+ global clients. 120,000 sq.ft. facilities located in Research Triangle Park, NC USA. FDA inspected and DEA registered.
Established in 2012, EFRAC is a USFDA Inspected & BSE Listed Company having ISO
17025:2005 Accreditation in Chemical & Biological disciplines. Drugs & Cosmetics Division at
EFRAC is and advanced Pharmaceutical Testing Facility with Cutting-Edge Technology, 21 CFR Part
11 enabled & DQ, IQ, OQ, PQ, Qualified Instrumentation. EFRAC conducts a wide range of Tests in
Strict adherence to the Scientifically Approved Protocols and Standards by Drug Regulators like
CDSCO, WHO, MHRA & USFDA.
Anecto's ISO 17025 accredited test facility provides world class support to product developers, designers and manufacturers. The state of the art laboratory is supported by technologists and engineers who also design and manufacture specialist products and support customer's warranty programmes.
With over 12 years experience as a company providing Product and Packaging Testing, Consultancy, Support, Bespoke Test Equipment and Protocol Development to the Medical Device Industry Anecto understands and responds to those challenges.
Anecto have a totally up to date knowledge of, understanding of and adherence to the pertinent regulations and standards stipulated by the FDA, the European Medical Device Directive, ISO 11607. We also understand that our clients successful compliance may require a combination of these and other relevant regulation depending on where in the world the product is to be distributed
Scynexis Fully Integrated Drug Discovery & Development 2011 Overviewbrycechaney
SCYNEXIS provides fully-integrated contract research solutions including medicinal chemistry, discovery biology, ADMET-PK, bioanalysis and analytical chemistry, process chemistry and cGMP manufacturing. We have delivered 11 Preclinical Candidates (PCCs) to our clients since 2005. We are FDA and DEA inspected.
Ask yourself - Do you want compounds... Or do you want DRUGS?
Almac: Development and Scale-up of a Photochemical Route to a Steroidal APISusan1Beattie
Presentation given by Dr Stephen Bell of Almac describing the development and Scale-up of a Photochemical Route to a Steroidal API at OPRD meeting on 25th September 2013 in Lisbon.
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...KBI Biopharma
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to Bedside
Abhinav A.Shukla, Ph.D. Senior Vice President, Process Development & Manufacturing, KBI Biopharma
Prof.Barton Haynes,M.D.Director,Duke Human Vaccine Institute
Innovative Drug Pipeline Solutions: Medicinal Chemistry, Process Chemistry, cGMP API Manufacturing. 105+ global clients. 120,000 sq.ft. facilities located in Research Triangle Park, NC USA. FDA inspected and DEA registered.
Established in 2012, EFRAC is a USFDA Inspected & BSE Listed Company having ISO
17025:2005 Accreditation in Chemical & Biological disciplines. Drugs & Cosmetics Division at
EFRAC is and advanced Pharmaceutical Testing Facility with Cutting-Edge Technology, 21 CFR Part
11 enabled & DQ, IQ, OQ, PQ, Qualified Instrumentation. EFRAC conducts a wide range of Tests in
Strict adherence to the Scientifically Approved Protocols and Standards by Drug Regulators like
CDSCO, WHO, MHRA & USFDA.
Anecto's ISO 17025 accredited test facility provides world class support to product developers, designers and manufacturers. The state of the art laboratory is supported by technologists and engineers who also design and manufacture specialist products and support customer's warranty programmes.
With over 12 years experience as a company providing Product and Packaging Testing, Consultancy, Support, Bespoke Test Equipment and Protocol Development to the Medical Device Industry Anecto understands and responds to those challenges.
Anecto have a totally up to date knowledge of, understanding of and adherence to the pertinent regulations and standards stipulated by the FDA, the European Medical Device Directive, ISO 11607. We also understand that our clients successful compliance may require a combination of these and other relevant regulation depending on where in the world the product is to be distributed
Scynexis Fully Integrated Drug Discovery & Development 2011 Overviewbrycechaney
SCYNEXIS provides fully-integrated contract research solutions including medicinal chemistry, discovery biology, ADMET-PK, bioanalysis and analytical chemistry, process chemistry and cGMP manufacturing. We have delivered 11 Preclinical Candidates (PCCs) to our clients since 2005. We are FDA and DEA inspected.
Ask yourself - Do you want compounds... Or do you want DRUGS?
Almac: Development and Scale-up of a Photochemical Route to a Steroidal APISusan1Beattie
Presentation given by Dr Stephen Bell of Almac describing the development and Scale-up of a Photochemical Route to a Steroidal API at OPRD meeting on 25th September 2013 in Lisbon.
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...KBI Biopharma
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to Bedside
Abhinav A.Shukla, Ph.D. Senior Vice President, Process Development & Manufacturing, KBI Biopharma
Prof.Barton Haynes,M.D.Director,Duke Human Vaccine Institute
Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...Susan1Beattie
Almac's Steven McIntyre presented in June 2012 at the second Irish Peptide Symposium regarding the manufacture of peptides for clinical trials. See his presentation here.
Dear Sir,
I take pleasure in introducing STABICON LIFE SCIENCES, a focused Analytical Methods Development/Validation & Stability Centre.
Stabicon Life Sciences is a Contract Research Organization. Services provided by Stabicon currently include specialized and focused services for complete stability study management including storage of samples, analysis and preparation of required documentation, associated analytical method development and validations for different phases of drug development program.
We are committed to complete confidentiality and protection of client’s intellectual property. We are committed to quality and reliability of our service. We also remain committed to our customers to deliver on agreed objectives and committed timelines and a promise to ourselves to be a reliable partner fulfilling requirements of our customer’s .Now we have been approved by few National & Multinational companies, who have now placed order with us for conducting stability studies on their products. We have been audited on behalf of Health Canada and have been approved for performing analytical and stability work for Canadian companies. We are also in process getting registration of our company with USFDA as cGMP testing analytical company located outside United States.
We have come across your company as a reputed organisation.We are looking for business partners with whom we can associate by acting as your back office support from India. By doing this it will allow you to allocate your resources for strategic projects. It will also allow you to save on your budgets significantly by taking advantage of Indian costs with International Quality Services offered by Stabicon.You may please visit our website www.stabicon.com for more details.
Looking forward to your response.
Thanking you and assuring our best service at all time.
Regards,
Vijay
Project Director
Stabicon Life Sciences Pvt Ltd
Mobile: +919591974355/080-41714280
www.stabicon.com
Fully-Integrated Services for Global Therapeutics Development: Accelerating Progress and Time to Market with integrated CDMO Platforms and Laboratory Testing Services. WuXi Advanced Therapies leverages decades of laboratory testing experience to get your product to market faster and with greater predictability, by overcoming common industry constraints.
Integrity Bio is a protein formulation development, fill finish, and drug delivery CMO. Injectable formulations include protein,antibody, vaccine, and peptide. http://www.integritybio.com
1. Solid State Services
Supporting the development of APIs
from invention to launch
> Polymorph Studies
> Physical Form Screening & Selection
> Crystallisation Development
> Troubleshooting
> Physical Form Characterisation
> Analytical Method Development
& Validation
> Counterfeit Analysis
> Scientific Litigation &
Prosecution Support
> Inhalation Services
> Preformulation Support
API Services &
Chemical Development
www.almacgroup.com
2. Commercial Services
Solid State Services Scientific Litigation and
Prosecution Support
Supporting the development of APIs from invention to launch
Almac’s Physical Sciences Group has extensive experience of API development, our comprehensive range
Providing expertise in Pharmaceutical IP from expert witnessing to prosecution support
Clinical Technologies
of solid state services and know-how will help strengthen the success of your product. Our solid form
investigations are driven by science not robotics, with highly trained chemists and analysts directing the Almac has served the global pharmaceutical industry for over 30 years in discovery, process development,
studies. These scientists have the ability to solve virtually any problem presented to them. They know manufacturing, formulation and clinical services, offering the most comprehensive range of integrated drug
that finding and consistently producing the drug in its optimal physical form is vital to the success of development services. We can utilise over 300 highly skilled scientists who are organic chemists, solid state
your drug development programme. chemists, analysts, and formulation scientists, operating in state of the art facilities. Our expertise, built from a
Clinical Trial Supply
large volume of diverse projects, puts us in a unique position to provide expert witnessing services to pharma
litigation cases as a testifying or non-testifying witness. We provide services to both infringement and
Paragraph IV cases.
Polymorph Characterisation We provide technical expertise to assist in successful patent prosecution. This service includes technical
> Screening > Drug substance consultancy for IP and technical support for successful prosecution to overcome rejections and oppositions.
Analytical Services
> Selection > Drug product
> Stable form determination
Routine Analyses
Physical Form Screen & > Lot release
Selection > GMP compliant
Expert Witness Services IP Support Services
> Salt, cocrystal &
Pharmaceutical Development
amorphous screens Analytical Method Development Infringement support Intellectual Property Support
> Selection of optimum form & Validation > Laboratory testing of API & drug product > Technical consultancy
for development > Lot release & regulatory > API solid form analysis in the drug product > Laboratory testing to strengthen the patent
> Reproducible solid form compliance > Reverse engineering of drug products
of the API > Strategy development Patent Application & Prosecution
Counterfeit Analysis > Expert report > Prior art reproduction
Troubleshooting: > Impurity profile > Expert witnessing > Reproduction of specifications & examples
API Issues > API solid form analysis in the
> Crystallinity, solubility, stability, drug product Paragraph IV litigation support Patent Opposition Support
> Reverse engineering of > ANDA reproduction of API & drug product > Laboratory testing
API Services & Chemical Development
purification & yield
drug products > Laboratory testing of API & drug product > EPO hearing
> Batch to batch variation
> Scale up problems > Strategy development
Inhalation Services > Expert report
Drug Product Issues > Particle engineering > Expert witnessing
> Dissolution > Cocrystals
> Stability > Micronisation
> Amorphous content & control
Crystal Engineering > Moisture content &
> Crystal modification hygroscopicity
Crystallisation Development
> Process development, scale-up
Biomarker Discovery & Development
3. www.almacgroup.com
Commercial Services
Preformulation Services
Design and development capability for small molecules and biologics
Clinical Technologies
Our preformulation studies are designed to identify and select the optimal physical form of your
API. We know that by possessing a thorough understanding of the properties of your drug
substance, we can reduce the number of problems in development, lower development costs
and decrease development time.
Clinical Trial Supply
Determining & assessing the Peptide structural characterisation
solid state properties > LC-MS
> Crystallinity > Absorption & fluorescence
> Hygroscopicity spectroscopy
> Particle size, shape & > Circular dichroism spectroscopy
surface area > NMR
Analytical Services
> Moisture/solvent content
Peptide chemical stability
Solid state stability > Solution state chemical stability to
Solution state stability acid, base, oxidising media, light &
Plasma stability elevated temperatures
> Solid state chemical stability to
Biopharmaceutical profiling light, humidity & temperature
Pharmaceutical Development
> pH-solubility profile & pKa
determination
Formulation development studies
> Permeability & BCS classification
> Effect of pH
> Solubility in pharmaceutical
> Buffer concentration & buffer type
solvents
> Surfactants
> Solubility in physiological buffers
> Complexing agents
> Polymers & cosolvents
Animal formulation
development Compatibility & stability studies
> pH modifications > In a range of containers & closures;
API Services & Chemical Development
> Cosolvents assessed for peptide adsorption,
> Surfactants compatibility, glass leachates &
> Cyclodextrin inclusion complexes particulate formation.
> Lipid based formulations
Other parameters assessed:
Clinical formulation > Osmolarity
> Micronised powders/suspensions > Viscosity
> Solid/waxy dispersions > pH
> Lipid based formulations > Appearance
> Drug in capsule/bottle > Needle flowability
> Identification of impurities
during stress studies
Biomarker Discovery & Development
For European Enquiries: For American Enquiries:
Almac Almac Group Incorporated
Sciences 25 Fretz Road
Almac House Souderton, PA 18964
20 Seagoe Industrial Estate, United States of America
Craigavon, BT63 5QD, T +1 (215) 660 8500
United Kingdom. E: sciences@almacgroup.com
T: +44 (0) 28 3833 2200
E: sciences@almacgroup.com
www.almacgroup.com